CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 341 enrolled
Drug / intervention
Treatment Phase 2 +2 moredrug
Likely dose
Fludrocortisone (Phase 2); individualized thereafter (Phase 3)AI-extracted
Key inclusion· 1
  • ✓Admitted to Vancouver VA Nursing Home or Rehabilitation ward
Key exclusion· 3
  • ✕Unable to stand upon admission
  • ✕Hospice admission
  • ✕Respite admission

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00117585
NCT00117585N/ACompleted
CompareCT.gov

Orthostatic Hypotension in Rehabilitation Patients

VA Office of Research and Development·interventional·Posted Jul 7, 2005·Updated Apr 18, 2016

In Brief

A clinical study evaluating Treatment Phase 1, Treatment Phase 2, and 1 other intervention for Hypotension, Orthostatic. Completed, enrolled 341 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the prevalence and clinical course of orthostatic hypotension (OH) on a rehabilitation and nursing home unit during their inpatient stay and to initiate a standardized, interdisciplinary treatment plan for patients with OH and determine the effect of treatment on the clinical course of OH during their inpatient stay.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypotension, Orthostatic
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 7, 2005
Enrollment StartNov 1, 2005
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 21.0 years ago

Interventions

Treatment Phase 1other

* Patient Education * Physical Therapy Exercises * Increased Salt Intake * Elevation of head of bed with 2-4 inch wedge * Medication Review by MD, Pharma

Treatment Phase 2drug

Subjects receive Treatment Phase 2 if they are still orthostatic after receiving Treatment Phase 1. * Fludrocortisone * Salt tablet

Treatment Phase 3other

Subjects still experiencing orthostatic hypotension after receiving Treatment Phases 1 and 2 move on to Treatment Phase 3. Individualized treatment is based on subspecialty or orthostatic hypotension consultation at the medical center. Subjects are followed for the duration of their hospital stay, on average 4 weeks.